MarketCap
Facebook
X
TelegramAnnual report 2025
added 11-25-2025
Becton, Dickinson and Company Cash Conversion Cycle 2011-2025 | BDX
Annual Cash Conversion Cycle Becton, Dickinson and Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110 | 109 | 96 | 88.3 | 86.9 | 110 | 110 | 109 | 113 | 107 | 144 | 148 | 157 | 146 | 149 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 157 | 86.9 | 119 |
Quarterly Cash Conversion Cycle Becton, Dickinson and Company
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 171 | 164 | 157 | 157 | 152 | 163 | 164 | 173 | 172 | - | 80.4 | 152 | 120 | - | 140 | 143 | 115 | 72.8 | 171 | 136 | 134 | 74.4 | 153 | 153 | 130 | 75.1 | 148 | 160 | 175 | 78.8 | 161 | 155 | 134 | 72 | 141 | 163 | 144 | 86.6 | 140 | 141 | 168 | 88 | 181 | 186 | 171 | 58.3 | 184 | 183 | 173 | 54.7 | 177 | 185 | 171 | 57.6 | 181 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 186 | 54.7 | 140 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
262 | $ 18.99 | 0.48 % | $ 9.68 B |  USA |
 |
BioLife Solutions
BLFS
|
37.9 | $ 24.43 | -1.81 % | $ 1.13 B | USA |
 |
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
266 | $ 4.79 | 2.35 % | $ 96.6 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
63.9 | $ 11.59 | -0.13 % | $ 2.36 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
134 | $ 78.74 | -0.03 % | $ 40.4 B |  Schweiz |
 |
iRhythm Technologies
IRTC
|
58.7 | $ 170.09 | 0.58 % | $ 5.31 B | USA |
 |
AtriCure
ATRC
|
185 | $ 42.08 | 1.62 % | $ 1.98 B | USA |
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
2.97 | $ 4.81 | -0.21 % | $ 26.5 K | USA |
 |
Harvard Bioscience
HBIO
|
208 | $ 0.76 | 1.78 % | $ 32.2 M | USA |
 |
AngioDynamics
ANGO
|
124 | $ 13.12 | -2.42 % | $ 536 M | USA |
 |
The Cooper Companies
COO
|
210 | $ 81.82 | -0.36 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
143 | $ 147.72 | 0.34 % | $ 3.6 B | USA |
 |
Glaukos Corporation
GKOS
|
170 | $ 109.57 | 0.31 % | $ 5.31 B | USA |
 |
Haemonetics Corporation
HAE
|
217 | $ 83.2 | -1.49 % | $ 4.19 B | USA |
 |
InfuSystem Holdings
INFU
|
24.9 | $ 9.24 | 0.33 % | $ 191 M | USA |
 |
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | USA |
 |
Repro Med Systems
KRMD
|
149 | $ 5.75 | -1.88 % | $ 262 M | USA |
 |
LeMaitre Vascular
LMAT
|
28.7 | $ 83.51 | 0.18 % | $ 1.87 B | USA |
 |
Intuitive Surgical
ISRG
|
208 | $ 541.3 | -1.11 % | $ 192 B | USA |
 |
Masimo Corporation
MASI
|
83.7 | $ 138.1 | -2.25 % | $ 7.36 B | USA |
 |
Merit Medical Systems
MMSI
|
171 | $ 86.52 | -0.01 % | $ 5.04 B | USA |
 |
Microbot Medical
MBOT
|
-52.9 | $ 2.43 | 2.21 % | $ 24.8 M |  Israel |
 |
Milestone Scientific
MLSS
|
545 | $ 0.39 | 9.69 % | $ 31.1 M | USA |
 |
Nephros
NEPH
|
161 | $ 5.08 | 2.24 % | $ 52.8 M | USA |
 |
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | USA |
 |
ResMed
RMD
|
167 | $ 250.7 | -0.67 % | $ 36.6 B | USA |
 |
Envista Holdings Corporation
NVST
|
79.4 | $ 21.79 | -1.58 % | $ 3.75 B | USA |
 |
OraSure Technologies
OSUR
|
167 | $ 2.52 | -2.14 % | $ 188 M | USA |
 |
Pro-Dex
PDEX
|
193 | $ 43.83 | 0.6 % | $ 144 M | USA |
 |
Pulse Biosciences
PLSE
|
36.5 | $ 14.26 | 3.71 % | $ 685 M | USA |
 |
Predictive Oncology
POAI
|
-241 | $ 5.95 | 0.51 % | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
272 | $ 156.65 | -3.1 % | $ 8.73 M | USA |
 |
Retractable Technologies
RVP
|
250 | $ 0.83 | -0.31 % | $ 24.8 M | USA |
 |
STAAR Surgical Company
STAA
|
26 | $ 24.16 | -2.11 % | $ 1.19 B | USA |
 |
STERIS plc
STE
|
112 | $ 251.01 | -0.59 % | $ 24.7 B | USA |
 |
Stereotaxis
STXS
|
212 | $ 2.38 | -1.45 % | $ 192 M | USA |
 |
Teleflex Incorporated
TFX
|
183 | $ 125.81 | -1.13 % | $ 5.89 B | USA |
 |
Utah Medical Products
UTMD
|
280 | $ 57.99 | 0.5 % | $ 210 M | USA |
 |
West Pharmaceutical Services
WST
|
98.9 | $ 266.92 | -2.06 % | $ 19.5 B | USA |